Oraya Therapeutics 

Oraya Therapeutics, Inc. is a privately-held company developing innovative and non-invasive therapies for diseases of the eye. The company was founded in 2007.

Oraya Therapeutics in the News

• 04.18.13

  Oraya Therapeutics’ INTREPID Study Published in Ophthalmology, the Official Journal of the American Academy of Ophthalmology

• 02.28.13

  Oraya Therapy(TM) Continues to Show Efficacy for Wet Age-Related Macular Degeneration

• 12.11.12

  New Therapy for Wet AMD Launched by Oraya Therapeutics and Optegra Eye Hospital Group

• 11.22.12

  Trial Data Shows Oraya Therapy Significantly Reduces Anti-Vegf Injections For Wet AMD

• 09.20.12

  Successful INTREPID Study Outcomes Presented at EURETINA 2012 Congress

• 05.03.12

  Oraya Therapeutics Achieves Successful INTREPID Study Outcomes With a Non-Invasive Radiation Therapy for Wet AMD